|

SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access

RECRUITINGSponsored by European Organisation for Research and Treatment of Cancer - EORTC
Actively Recruiting
SponsorEuropean Organisation for Research and Treatment of Cancer - EORTC
Started2017-05-03
Est. completion2026-03
Eligibility
Age12 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT02834884

Summary

SPECTA is a quality assured platform for collecting clinicopathologically annotated biological material, imaging data, operative images, environmental assessment, questionnaires as well as patient-reported outcomes from cancer patients to support biospecimen-based translational research and clinical cancer research, including biomarker discovery to improve the understanding of tumor biology and cancer patients care.

Eligibility

Age: 12 Years+Healthy volunteers accepted
* Patients with pathologically confirmed selected tumor types (at site or centrally);
* Mandatory availability of adequate human biological material (HBM);
* Centrally performed confirmation of HBM adequacy in terms of quality and quantity for SPECTA downstream project requirements;
* Age ≥ 12 years;
* Absence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule;
* Written informed consent according to applicable legal and ethical requirements;

Conditions2

All Tumor TypesCancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.